FGD2 antibody

Principal name

FGD2 antibody

Alternative names for FGD2 antibody

ZFYVE4, FYVE, RhoGEF and PH domain-containing protein 2, Zinc finger FYVE domain-containing protein 4

SwissProt ID

Q7Z6J4 (Human), Q8BY35 (Mouse)

Gene ID

221472 (FGD2), 26382 (Fgd2)

Background of FGD2 antibody

Kit Component:
- KN305915G1, Fgd2 gRNA vector 1 in pCas-Guide vector
- KN305915G2, Fgd2 gRNA vector 2 in pCas-Guide vector
- KN305915D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector
CRISPR Manual:
CRISPR/CAS9 Genome Editing Manual

6 Item(s)

per page

Proteins & Growth Factors

Catalog No. Species Pres. Purity Source  

FGD2

FGD2 Human > 80 %
Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps.
Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining.
HEK293 cells

Regular Price: 20 µg / €680.00

Special Price: 20 µg / €398.00

  OriGene Technologies, Inc.

FGD2

FGD2 Human Purified 12.5% SDS-PAGE Stained with Coomassie Blue.
10 µg / €380.00
  Abnova Taiwan Corp.

FGD2

FGD2 Human Purified 12.5% SDS-PAGE Stained with Coomassie Blue.
25 µg / €510.00
  Abnova Taiwan Corp.

Lysates

Catalog No.    

FGD2 overexpression lysate

FGD2 overexpression lysate  
0.1 mg / €280.00
  OriGene Technologies, Inc.

Human Lenti ORF Particles

Catalog No.    

Lenti ORF particles, FGD2 (mGFP-tagged) - Human FYVE, RhoGEF and PH domain containing 2 (FGD2), 200 uL, >10^7 TU/mL

Lenti ORF particles, FGD2 (mGFP-tagged) - Human FYVE, RhoGEF and PH domain containing 2 (FGD2), 200 uL, >10^7 TU/mL  
200 µl / €1,050.00
  OriGene Technologies, Inc.

Lenti ORF particles, FGD2 (Myc-DDK tagged) - Human FYVE, RhoGEF and PH domain containing 2 (FGD2) , 200 uL, >10^7 TU/mL

Lenti ORF particles, FGD2 (Myc-DDK tagged) - Human FYVE, RhoGEF and PH domain containing 2 (FGD2) , 200 uL, >10^7 TU/mL  
200 µl / €940.00
  OriGene Technologies, Inc.

6 Item(s)

per page
  • LinkedIn